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Abstract. We examined the association of a  34-kD 
light chain component to the heavy chains of MAP-1 
using a monoclonal antibody that specifically binds 
the 34-kD component and labels neuronal microtu- 
bules in a specific and saturable manner. Immunopre- 
cipitation of MAP- 1 heavy chains together with the 
34-kD component by the antibody indicates that the 
34-kD polypeptide forms a complex with MAP-1 
heavy chains. Both major isoforms of MAP-1 heavy 
chains (MAP-1A and MAP-1 B) were found in the 
immunoprecipitate. Digestion of MAP- 1 with alpha- 
chymotrypsin and analysis of the chymotryptic pep- 
tides reveals a  120-kD fragment of the MAP-1 heavy 
chain that binds to microtubules and is precipitable 
with the 34-kD light chain antibody, suggesting that 
the 34-kD light chain also binds to this domain of the 
molecule. Since microtubules that contain the 120-kD 
fragment lack the long lateral projections characteris- 
tic of microtubules with intact MAP-l, the 34-kD 
light chains may be localized at or near the microtu- 
bule surface. 
M 
ICROTUBULES isolated from brain tissue extracts are 
composed of tubulin plus several microtubule-as- 
sociated proteins (MAPs). ~  Of these, two classes of 
high molecular weight components termed MAP- 1 and MAP- 
2 have been demonstrated to co-purify with tubulin during 
cycles of microtubule assembly and disassembly and to stim- 
ulate microtubule assembly in vitro (for a review see reference 
22). There is considerable evidence that MAPs may mediate 
the binding of membranous organelles, actin filaments, and 
intermediate filaments to microtubules, leading to the specu- 
lation that they may therefore be important for cellular proc- 
esses such as mitosis and organelle transport, and for deter- 
mining the dynamic properties  of the cytoskeleton. Immu- 
nofluorescence microscopic studies on the distribution of the 
brain high molecular weight MAPs have shown that MAP-2 
is localized primarily in the dendrites of neurons in brain (2, 
12) and possibly in small amounts in other cells (6,  17, 23), 
most notably chromatophores (18). In contrast,  MAP-1  is 
more generally distributed, being found in both dendrites and 
axons of neurons and in glial cells in brain,  in chromato- 
phores, and on both interphase and mitotic microtubules in 
various tissue culture cells, suggesting that MAP-1 may have 
a more general function (1, 18). 
Recently MAP-I  has been isolated and demonstrated to 
stimulate tubulin assembly in vitro (7, 8, 21) and to exhibit 
structural characteristics  similar to those of MAP-2 as 20-nm 
Abbreviations used in this paper." LC- 1, LC-2,  light chains 1 and 2 of MAP- 1; 
MAP, microtubule-associated protein; PMSF, phenylmethylsulfonyl fluoride. 
long projections on  microtubule surfaces  (9,  21). Purified 
preparations of MAP-I  from bovine brain have also  been 
demonstrated to contain at least two low molecular weight 
components that remain tightly associated with MAP- 1 heavy 
chains during ion-exchange chromatography and during gel 
filtration chromatography under nondenaturing conditions. 
The stoichiometric ratio of both light chains to one MAP- 1 
heavy chain is approximately 1:1 (21 ). 
In this paper we examine further the relationship of  the low 
molecular weight components to MAP-1 heavy chain using a 
monoclonal antibody to  the  larger  of the  two light chain 
components and describe the location of this polypeptide on 
a microtubule-binding, chymotryptic peptide of the MAP-l 
heavy chain at or near the microtubule surface. 
Materials and Methods 
Biochemical Procedures 
Microtubules, MAPs, MAP-I, and tubulin were purified from bovine brain in 
a  buffer containing 50  mM imidazole-HCl  (pH 6.7),  50  mM KC1, 0.5  mM 
MgCI2, 0.1  mM  EDTA,  1 mM GTP,  1 mM  2-mercaptoethanol (buffer A) 
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF). Unfraction- 
ated microtubule proteins were prepared by two cycles of assembly-disassembly 
(16) as modified by Rodionov et al. (14).  Tubulin and MAPs were separated 
by chromatography on phosphocellulose in buffer A with 1 mM PMSF (25). 
MAP-I was purified as described in reference 7. Purified MAP-I was often 
contaminated with polypeptides of lower molecular weight, including polypep- 
tides that co-migrated with MAP-2 during SDS PAGE (see, for example, Fig. 
1, lane C and Fig. 6A, 0 rain). These polypeptides accumulated in preparations 
during storage, suggesting that they are products of MAP-l  proteolysis. Im- 
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this polypeptide or its degradation products in purified MAP-I preparations. 
Microtubule-hinding activity  of the MAPs and their proteolytic fragments 
was  determined by a  sedimentation assay  in the presence of microtubules. 
Samples of total MAPs or purified MAP-I were clarified by centrifugation  at 
150,000 g for 30 min. Microtubules were prepared by polymerizing  phospho- 
cellulose-purified  tubulin  (0.8-1.0  mg/ml) at  37"C for 30  min  in  buffer A 
supplemented with 10 t*M taxol,  1 mM GTP, and 1 mM EGTA. Microtubule 
assembly was monitored by light scattering at 330 nm (3). The fraction to be 
tested was added to the taxol-microtubules (1:10 MAP peptide/tubulin ratio), 
and after 30 min of incubation at 37"C, microtubules were pelleted for 30 min 
at 200,000 g (SW 50.1 rotor, Beckman Instruments  Inc., Palo Alto, CA) through 
a  cushion of 4  M glycerol in buffer A with 1 mM EGTA.  The pellets were 
solubilized  in  1%  SDS and analyzed by SDS  PAGE.  A  33  kD-protein that 
inhibits tubulin polymerization was purified from bovine brain according to 
Kotani et al. (4). Another 35-kD microtubule-binding protein (glyceraldehyde- 
3-phosphate dehydrogenase)  was prepared according to Kumagai  and Sakai 
(5). 
SDS PAGE was performed according to Laemmli (10) in 7 or 10% polyac- 
rylamide slab gels at an acrylamide to N,N'-methylene-bisacrylamide ratio of 
100:1 (wt/wt). To resolve MAP-1 heavy chain isoforms by SDS gel electropho- 
resis we used tube gels containing a 4-10% linear gradient of polyacrylamide 
(acrylamide to N,N'-methylene-bisacrylamide  ratio of 100:1) in the phosphate 
buffer system of Weber and Osborn (24). Coomassie Blue-stained gels, quan- 
titated by densitometry at 500 nm, were found to be within the linear range of 
absorbancc as a function of protein concentration. 
Protein concentration was determined by the method of Lowry et al. (11) 
using bovine serum albumin as a standard. 
Immunological Procedures 
The  production of a  monoclonal antibody (El2)  to  the  34-kD  MAP was 
described  previously  by Rodionov et al. (15).  This antibody was of the igG 
class. Monoclonal antibodies to tubulin (Tu 0.1) and to MAP-2 (MA 1) were 
generously provided by Drs. P. Draber and V. Vicklicky (Institute of Molecular 
Genetics, Prague, Czechoslovakia). 
Immunoblotting was performed according to Towbin et al. (19) as modified 
by  Rodionov et  al.  (15).  Antibody-reactive  components were  revealed  by 
incubation in 4-chloro-l-naphthol (0.5 mg/ml) in 50 mM Tris-HCl  (pH 7.5) 
containing 0.05% H202. 
For immunoprecipitation, total MAPs (0.3-0.4  mg/ml) or alpha-chymo- 
trypsin-treated MAP-I (0.15-0.20  mg/ml) was incubated with El2 antibody 
(0.4-0.6 mg/ml) for 3 h in buffer A at room temperature. Monospecific rabbit 
antibody against mouse lgG was added to a final concentration of  0.5-0.7 mg/ 
ml, and after 30 rain of incubation at room temperature, immunoprecipitates 
were collected by pelleting  at  150,000 g  for 20  min through a layer of 4 M 
glycerol and 0.5  M  KCI in buffer A. The precipitates  were dissolved  in  10% 
SDS  and  5%  2-mercaptoethanol and analyzed by  SDS  gel electrophoresis. 
Small amounts of insoluble  material  usually remained in the immunoprecipi- 
rates, even after heating the samples in gel sample buffer containing 10% SDS 
and  10% beta-mercaptoethanol. However, the amounts of this insoluble  ma- 
terial were small (<1%), did not contain LC-I, as determined by immunoblot- 
ting using a  monoclonal antibody to LC-I  (Fig.  8B),  and therefore did not 
interfere with our gel electrophoretic  analyses of LC-1 in immunoprecipitates. 
Microscopy 
For immunofluoreseence  staining, twice-cycled microtubules at 1.0-1.5 mg/ml 
in buffer A were adsorbed onto glass coverslips pretreated with poly-L-lysine (1 
mg/ml). After adsorption microtubules were fixed with 4% formaldehyde in 
phosphate-buffered saline (PBS). Fixed microtubules were thoroughly washed 
with PBS, treated with I% bovine serum albumin for 30 min, and then stained 
with the antibodies by the indirect method. El2 antibody (ascites) was used at 
a concentration of ~1  mg/ml. 
For electron microscopy pelleted microtubules were fixed overnight with 1% 
glutaraldehyde  in  10 mM sodium phosphate buffer (pH 7.0) containing 1% 
tannic acid and postfixed  with  1% OsO4. Samples were stained with  uranyl 
acetate in ethanol at  70"C and after ethanol-acetone dehydration were em- 
bedded in Epon. Ultrathin sections stained with lead citrate (13) were examined 
and photographed on an Hitachi  HU-I IB electron microscope (Hitachi Ltd, 
Tokyo) operated at 75 kV. 
Materials 
Alpha-chymotrypsin (type VII TLCK treated)  and molecular weight markers 
were purchased from Sigma Chemical Co. (St. Louis, MO); phosphocellulose 
(P-I 1) was from Whatman Chemical  Separation,  Inc. (Clifton, N  J); taxol was 
from the National Cancer Research Institute (Bethesda, MD). 
Results 
Demonstration of  Antibody Specificity 
We prepared monoclonal  antibodies to a  total MAP  fraction 
from  bovine  brain  microtubules  and  obtained  several  anti- 
bodies, one of  which binds specifically to a  34-kD component, 
which  we  demonstrate  in  this  paper  to  be  a  light  chain  of 
MAP-1.  The specificity of binding of this antibody (E-12)  is 
demonstrated  by  immunoblotting  in  Fig.  1.  The  antibody 
binds to a  single 34-kD polypeptide in preparations of cycled 
microtubules, total MAPs, and purified MAP-1. 
The 34-kD component  was determined to be distinct from 
the  35-kD  microtubule-binding  protein  (glyceraldehyde-3- 
phosphate dehydrogenase) isolated by Kumagai  and Sakai (5) 
and the 33-kD inhibitory factor of tubulin polymerization (4) 
(data not shown). 
Fig.  1 demonstrates that the procedure used to purify MAP- 
1 results in the purification of both MAP-1  heavy chains and 
two  low  molecular  weight  components  (31  and  34  kD)  as 
described by Vallee and Davis (21).  The binding of antibody 
to  native  cycled  microtubules  was  also  demonstrated  to  be 
saturable  in  a  microtubule  pelleting  assay  (Fig.  2),  which 
revealed that saturation was near that expected for equimolar 
binding of antibody to the 34-kD  component  as determined 
Figure 1. Demonstration of antibody specificity by immunoblotting. 
The figure shows Coomassie Blue-stained gels (lanes A-C) and cor- 
responding immunoblots (lanes a-c) for E-12 antibody to the 34 kD- 
light  chain  component  of MAP-I.  Lanes A  and  a,  microtubules 
prepared by two cycles of assembly and disassembly; lanes B  and b, 
total MAP fraction; lanes C and c, purified MAP-1. The antibody is 
specific for the 34-kD polypeptide associated with MAP-I. Numbers 
at left indicate molecular weight markers (x  103). 
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Figure 2.  Demonstration of the saturability of antibody binding to 
microtubules. Increasing amounts of E-12 antibody (0-360 ~g) were 
added to aliquots of a total MAP fraction (10/~g) and incubated for 
3  h  at  4"C. The  mixture  was  added  to  100  t~g of microtubules 
assembled from phosphocellulose-purified  tubulin in the presence of 
10 ~tM taxol, incubated for 30 rain at 37"C, and pelleted as described 
in  Materials and  Methods. The  amount of antibody  light chains 
present  in  the  resulting supernates and  pellets was estimated by 
densitometry of Coomassie Blue-stained SDS polyacrylamide gels. 
Only the antibody light chains were quantitated because lgG heavy 
chains migrate on SDS gels with an electrophoretic mobility close to 
that  of tubulin.  Examples of the resolution of LC-I  and antibody 
light chains after fractionation on 10% polyacrylamide  gels are shown 
in  Figs. 4, lane C and  5,  lane A. Saturation  of antibody  binding 
occurred  rapidly and  at  a  ratio  consistent with that  expected for 
specific binding. 
by densitometry of Coomassie Blue-stained polyacrylamide 
gels. The twofold difference in the molar ratio (one antibody/ 
two low molecular weight components) may be due to differ- 
ences in Coomassie Blue staining, heterogeneity of the anti- 
gen, or other factors. As expected, the antibody also stained 
cycled brain microtubules that were fixed before examination 
by immunofluorescence microscopy (Fig.  3). These observa- 
tions  establish  that  the  binding  of antibody  to  the  34-kD 
component of cycled brain microtubules is specific and sat- 
urable. 
The 34-kD Component Is a Light Chain of  MAP-1 
We demonstrated previously that purified fractions of MAP- 
1 contain two low molecular weight components with molec- 
ular weights of <40  kD (7).  Vallee and  Davis (21) showed 
that the low molecular weight components co-purify with the 
MAP- 1 heavy chain when MAP preparations are subjected to 
various chromatographic procedures. To confirm that MAP- 
1 preparations contain low molecular weight components and 
to show that the light chains were not binding to other MAPs 
such as MAP-2, we incubated antibody with a preparation of 
total high molecular weight MAPs and examined the com- 
position of supernates and pellets after immunoprecipitation 
with a rabbit anti-mouse IgG antibody. The immunoprecipi- 
tates were observed to contain both the  34-kD component 
and the heavy chain of MAP-1  (Fig.  4) but did not contain 
MAP-2,  which  remained  in  the  supernate.  However,  the 
pellets did contain a component with an electrophoretic mo- 
bility near that  of MAP-2,  but by immunoblotting using a 
MAP-2 specific antibody, it could be shown that this com- 
ponent  was  not  MAP-2  itself,  suggesting that  it  may be  a 
proteolytic fragment of the MAP-I heavy chain. Electropho- 
resis of MAP- l  on gradient gels in 0.1  M phosphate revealed 
Figure  3.  lmmunofluorescence microscopy of cycled microtubules 
stained with tubulin antibody (A) and with E-12 antibody (B). Micro- 
tubules were  adsorbed  onto  poly-L-lysine-treated glass  coverslips, 
fixed with formaldehyde, and stained with antibodies as described in 
Materials and Methods. No staining was observed using nonspecific 
ascites  and secondary fluorescent antibody or with the  secondary 
antibody alone (not shown). Bar, 5 ~m. 
that  MAP-1  contains  three  principal  heavy chains,  as  was 
demonstrated previously by Bloom et al. (2). Electrophoretic 
analysis  of immunoprecipitates  prepared  from  a  purified 
MAP-1  fraction revealed that the  34-kD component bound 
to at least two major classes (A and B) of the MAP-I heavy 
chains (Fig. 5). These observations demonstrate the specificity 
of binding of the 34-kD component to MAP-1 heavy chains 
and justify its designation as a light chain of MAP- 1 (LC- l). 
Antibody binding experiments showed that E-12 antibody 
interacts with MAP-1  both in  solution and on microtubule 
surfaces. Therefore, the site of antibody binding and the site 
of tubulin binding on the MAP-1 molecule may not overlap. 
The observation that preincubation of MAP-l with the anti- 
body does not inhibit the ability of  MAP- 1 to promote tubulin 
polymerization in  vitro is consistent with this interpretation 
(data not shown). 
Localization of  LC-1 on the Heavy Chain of  MAP-1 
We and others have shown previously that MAP-1 binds to 
the lateral surfaces of microtubules and contains a distinctive 
projection portion that can be distinguished by electron mi- 
croscopy after tannic acid staining and thin sectioning (9, 21). 
If partial proteolysis removed the projection portion of MAP- 
1 from microtubules as it does for MAP-2, we could use this 
method  to  determine  which  domain  of the  MAP-I  heavy 
chain binds LC-1. When preparations of purified MAP-1 free 
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with E-12 antibody. For immunoprecipitation, antibody (45/,g) was 
incubated for 3 h at room temperature with the total MAP fraction 
(30 ug), Rabbit monospecific antibody against mouse IgG (65 #g) was 
added, and after a 30-min incubation immunoprecipitates were col- 
lected and analyzed by Laemmli gel electrophoresis.  Lane A, starting 
total MAP fraction~ electrophoresis on 7% poIyacrylamide  gel; lanes 
B and (7,  immunoprecipitate, etectroohoresis on  7% (lane B)  and 
10%  (lane  C)  polyacrylamide gels.  The  prominent  bands  in  the 
immunoprecipitates shown in lanes B and C are the heavy and light 
chains of immunoglobulins. Only the heavy chains are resolved on 
the 7% gel shown  in lane B. Lanes D and E, immunobiots of the 
samples shown  in lanes A and B respectively,  stained with MAP-2 
antibody after electrophoresis on a  10%  gel.  Results  indicate that 
MAP-2 is stained in a control preparation of total MAPs (lane D) but 
is absent from the immunoprecipitate (lane E). Therefore,  the faint 
component  seen  in  both  lanes B  and  C  with  an  electrophoretic 
mobility similar to MAP-2 is not MAP-2 itself, but probably repre- 
senls a proteolytic fragment of the MAP-I heavy chain. 
Figure 5.  Precipitation of isoforms 
of MAP-I heavy chains by LC-1 an- 
tibody,  Immunoprecipitates  pre- 
pared as described in the legend to 
Fig. 4 were fractionated on tube gels 
(acrylamide gradient 4-10%,  acryl- 
amide/bisacrylamide  ratio, 100:1) in 
0.1 M phosphate, pH 7.0, to resolve 
the  heavy  chain  components  of 
MAP-I. The figure  shows  the high 
molecular weight region of two iden- 
tical  gels  containing  total  MAPs 
(lane A) and lhe corresponding im- 
munoprecipitate  (lane B).  Both  of 
the  major  MAP-1A and  MAP-1B 
isoforms of heavy chains were con- 
tained in the immunoprecipitate. 
of microtubules were digested with alpha-chymotrypsin, sev- 
eral peptides were formed, including a stable 120-kD fragment 
of the MAP-I  heavy chain, LC-1, and other minor compo- 
nents  (Fig,  6A).  When  the  peptide  mixture  was  combined 
Figure 6  Generation of a  stable  120-kD  fragment of MAP-I  by 
digestion with alpha-chymotrypsin and demonstration of its binding 
to  microtubules. (A) Time course of digestion of purified MAP-I 
shows the generation of a stable 120-kD fragment (digestion condi- 
tions: 6 ug MAP-I, 0.03  ~tg alpha-chymotrypsin, at room tempera- 
ture). The positions of molecular weight standards (x 103) are shown 
on the left. (B) Binding of proteolytic fragment of MAP-1 to micro- 
tubules. Proteolytic fragments were added to microtubules composed 
of phosphocellulose-purified  tubulin assembled in the presence of 10 
aM taxol, pelleted, and examined by gel electrophoresis.  Gel analysis 
of the microtubule pellets shows, in addition to lubulin, the specific 
b~nding of the 120-kD heavy c~aJ~ fragrner~t, LC-L p/as other trace 
comoonents. A and B are separate hut otherwise identical gels, hence 
the slight differences in electrophoretic mohilities. 
with taxol-stabilized microtubules containing phosphocellu- 
lose-purified tubulin (taxol microtubules) and pelleted, all of 
the  120-kD  fragment  and  LC-1  were  observed to  bind  to 
microtubules, as determined by sedimentation and gel elec- 
trophoresis (Fig. 6 B). Examination of thin sections of these 
pellets by electron microscopy revealed that a  considerable 
portion of the MAP-1 projection was absent (Fig, 7), indicat- 
ing that the fragments that bound-to microtubules were part 
of the microlubule-binding  domain of MAP-I. 
From this procedure alone, however, it was not possible to 
determine if LC-1  and the  120-kD  fragment of the MAP-I 
heavy chain  bound  to  microtubules independently or were 
associated together as a complex. To distinguish between these 
alternatives, we examined the composition of immunoprecip- 
itates of a  purified MAP-1 preparation after partial digestion 
with  chymotrypsin,  which  produced  the  120-kD  fragment 
(Fig. 8).  The immunoprecipitates contained both LC-1  and 
the  120-kD  heavy chain  fragment,  indicating that  the  two 
components are associated together in a complex. Thus, there 
ts no evidence to indicate that LC-I and MAF-I heavy chain 
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with alpha-chymotrypsin.  Purified MAP-1 (0.2 mg/ml) was treated 
with alpha-chymotrypsin  (1:200 enzyme/MAP1  ratio) for 3 rain  in 
buffer A at room temperature.  The reaction was arrested with 2 mM 
PMSF, and the  digest was added  to taxol-microtubules  assembled 
from phosphocellulose-purified tubulin.  Microtubules  were pelleted 
and prepared  for thin sectioning after staining with tannic acid as 
described  in  Materials  and  Methods.  (A) Control  preparation  of 
microtubules  decorated  with  undigested MAP-I; (B) decoration  of 
microtubules with chymotrypsin-digested MAP- 1. Enzyme treatment 
removes most of the MAP-1 projections. Bar, 0.1 ~m. 
bind independently to microtubules.  We also observed that 
the pattern  of cleavage products and peptide binding to mi- 
crotubules was the same when taxol-stabilized  microtubules 
containing both MAP-1  and MAP-2 were partially digested 
with chymotrypsin, pelleted, and examined by gel electropho- 
resis  and  immunoblotting  (Fig.  9).  No  differences  in  the 
pattern  of cleavage were observed, indicating that MAP- l  is 
cleaved similarly in both the bound and unbound states. 
Discussion 
With a  monoclonal antibody specific for the 34-kD compo- 
nent  (LC-I) of MAP-1  and an  immunoprecipitation  assay, 
we have  been  able to demonstrate that  LC-1  is tightly and 
specifically bound to MAP- 1 heavy chain and that LC- 1 shows 
no affinity for MAP-2.  Saturating  amounts  of antibody to 
LC-I  were observed to precipitate  most of the heavy chain 
components of MAP-I, including the two principal A and B 
isoforms of MAP-1. However, resolution of the immunopre- 
cipitates  was insufficient to  determine  if all  of the  MAP-1 
heavy chain species were present. This indicates that at least 
the  A  and  B  variants  of MAP-1  heavy chain  contain  light 
chain  binding sites and are  structurally related,  which is in 
agreement  with  previous comparisons by peptide  mapping 
(2).  This observation also suggests that  most of the MAP-1 
heavy chains are complexed with LC- 1. We also observed that 
LC-2 was removed from solution  by immunoprecipitation, 
Figure 8. lmmunoprecipitation  of chymotryptic fragments of MAP- 
I. Aliquots of purified MAP-1 (40 ~g) were digested for 0,  I, and 2 
rain at room temperature with alpha-chymotrypsin (0. lug), arrested 
with  2  mM  PMSF,  and  immunoprecipitated  as  described  in  the 
legend to Fig. 4. Antibody to LC-l pellets LC-l as well as the stable 
peptides of the MAP- 1 heavy chains (molecular weights 180 and 120 
kD), and intact  MAP-1 heavy chains. Digestion time in minutes  is 
indicated for each gel lane. Electrophoresis on 10% (A) and 7% (B) 
polyacrylamide gels. Comparison of lanes in A and B shows that 1-2 
rain  of hydrolysis leaves no MAP-1 heavy chains intact (B, lanes 1 
and 2). The material at the tops of the gel lanes (arrows) represents 
trace amounts of residual insoluble immunoprecipitates.  No condi- 
tions were found that completely dispersed these aggregates. 
but this observation was difficult to quantitate by gel electro- 
phoresis of immunoprecipitates,  since LC-2 was usually ob- 
scured by the presence of antibody light chains.  It therefore 
appears likely that MAP-1 heavy chains, LC-I, and LC-2 are 
associated together in a complex. 
Alpha-chymotrypsin cleaves MAP- 1 into peptides, some of 
which retain  the  ability to bind  to microtubules.  However, 
the  sizes  and  relative  amounts  of the  microtubule-binding 
peptides are different from those obtained from MAP-2 using 
the same enzyme treatment. This agrees with the observations 
made previously that MAP-l  and MAP-2 are different pro- 
teins as determined by partial proteolysis with Staphylococcus 
protease V8 or alpha-chymotrypsin and peptide analysis on 
Cleveland gels (7).  Under conditions  of limited  proteolysis 
with chymotrypsin, MAP-2 is cleaved into a  major 240-kD 
fragment  that  no  longer binds  to  microtubules  (projection 
portion)  and  32-39-kD  fragments  that  retain  microtubule- 
binding activity (microtubule-binding domain) (20). In con- 
trast, we observed that MAP-1 is cleaved into a large  120-kD 
proteolysis-resistant fragment that associates with both LC-1 
and LC-2 and contains microtubule-binding activity. A num- 
ber of other peptides of intermediate to low molecular weight 
were also generated but did not contain microtubule-binding 
activity. Since LC-1 is not strongly affected by limited prote- 
olysis and is associated with the 120-kD fragment, this molec- 
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MAPs.  Microtubules were prepared  by polymerization of phospho- 
cellulose-purified tubulin  in the presence of 10 ~m taxol, and total 
MAPs were added to the microtubule polymers. Polymers containing 
200 ug tubulin  and 20 tzg MAPs were digested with 0.05 ug alpha- 
chymotrypsin for 0-5  min at 37"C. Digestion was arrested  with  2 
mM PMSF, microtubules were pelleted, and pellets were analyzed by 
SDS gel electrophoresis (A) and immunoblotting (B). (A) Time course 
ofchymotryptic  digestion. A comparison of  the supernates and pellets 
shows the specific binding  of a  120-kD fragment  and other minor 
components (30-50 kD) to microtubules.  (B) Immunoblot of the 
same fractions shows that LC-I binds to microtubules and is affected 
relatively little by chymotrypsin treatment.  The sharp  reduction  in 
the amount of LC-I  seen  in the  immunoblot of the  microtubule 
pellet after  5 min is due primarily  to the prolonged digestion with 
chymotrypsin. 
ular association may in part account for the relative stability 
of the  120-kD peptide  from the MAP-1  heavy chain.  Thus, 
in contrast to digestion of MAP-2, digestion of MAP-I with 
chymotrypsin generates a  single  large peptide  that contains 
the microtubule-binding domain of the molecule as well as a 
site for the binding of LC- 1. 
So far it has not been possible to identify which components 
in the microtubule-binding domain of MAP-1 contain micro- 
tubule-binding  activity.  Our  antibody  does  not  block  the 
binding of MAP-1  to microtubules,  inhibit MAP-1  induced 
polymerization  of tubulin,  or  displace  MAP-1  from  pre- 
formed microtubules containing MAP-1. Therefore it is pos- 
sible  that  microtubule-binding  activity  is  not  contained  in 
LC-I  but  in  other  components  such  as  the  MAP-1  heavy 
chain or LC-2. Alternatively, LC-1 may bind to microtubules 
but at a site not blocked by the presence of bound antibody. 
Vallee and Davis (21) reported previously that MAP-I heavy 
chain, isolated by ion-exchange chromatography in the pres- 
ence of 6  M  urea,  binds weakly to microtubules, but it was 
not clear from this study if the low binding activity was due 
to the removal of MAP-1 light chains or to partial denatura- 
tion of the  protein.  To answer this  question definitively,  it 
would be desirable to examine the microtubule-binding activ- 
ity of native MAP-1 heavy chains in the presence and absence 
of MAP- 1 light chains. 
Although we can demonstrate the selective binding of LC- 
1 to the heavy chains of MAP- 1 and localize the light chain 
binding site to a  120-kD peptide  of MAP-l, we have so far 
been unable to demonstrate that LC-1 is specifically localized 
on microtubules in situ. LC-1 was not detected by immuno- 
blotting and microtubules were not labeled with the antibody 
in several different types of  tissue culture cells (mouse embryo 
fibroblasts, bovine tracheal epithelial cells [FBT cell line] and 
CHO cells).  It is possible  that  MAP-1  light chains in these 
cells are present in low amounts, or contain different antigenic 
sites,  or are absent.  However, it may be possible  to culture 
neuronal cells that contain more MAP-1 to determine if LC- 
1 is localized on microtubules in situ. With cultures of neu- 
ronal cells it may also be possible to inject  living cells with 
antibody,  and  by  observing  subsequent  cellular  behavior, 
ascertain  if LC-1  is important  for determining  some of the 
functions of microtubules in vivo. Further work will be re- 
quired to explore these possibilities. 
We thank N. V. Minina for excellent technical assistance and Drs. P. 
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